logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
O

Olivier Dubreuil

diaconesses-croix st simon hospital
H指数:21
被引数:3,043

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sequential alternation of nal-IRI/5-FU and gemcitabine/nab-paclitaxel versus nal-IRI/5-FU versus gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer: results of the randomized phase II PRODIGE 61—FUNGEMAX trial (France)

纳曲伊立替康/5-氟尿嘧啶与吉西他滨/阿帕他汀相比纳曲伊立替康/5-氟尿嘧啶与吉西他滨/阿帕他汀在一线转移性胰腺癌中的序贯交替方案：法国随机II期PRODIGE 61—FUNGEMAX试验结果

EClinicalMedicine
IF10
2026-05-290
OAAI
Julien Taieb; Simon Pernot; Frédéric Thuillier; Alexis Delattre; Erwan Vo-Quang; Caroline Petorin; Vincent Bourgeois; David Tougeron; Franck Audemar; Carole Vitellius; Laurent Mosser; Jérôme Desrame; Frédéric Di Fiore; Yves Rinaldi; Anna Pellat; Marion Bolliet; Fabienne Watelle; Hervé Perrier; Olivier Dubreuil; Come Lepage
Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II study

二氢嘧啶脱氢酶表型指导的氟嘧啶在胃肠道癌症中的剂量个体化：PRODIGE100-UCGI48-FUDOSE II期研究

Digestive and Liver Disease
IF3.8
2026-05-220
OAAI
G.M. Camilleri; M.A. Loriot; G. Le Teuff; F. Thuillier; O. Bouche; C. Narjoz; M. Ben Abdelghani; C. Herve; S. Corbinais; C. Locher; T. Lecomte; M. Villemin; D. Tougeron; C. Lepage; A. Peytier; AS Moussaddaq; O. Dubreuil; M. Mabro; J. Desrame; N. De Sousa Carvalho
Neoadjuvant chemotherapy for obstructive colon cancer derived by a stoma: Study protocol of the FRENCH-01 randomized phase III trial (COnCERTO Trial)

由造口术衍生的梗阻性结肠癌的新辅助化疗：FRENCH-01随机III期试验（COnCERTO试验）研究方案

Digestive and Liver Disease
IF3.8
2026-04-060
OAAI
Valérie Bridoux; Benjamin Fernandez; Charles Sabbagh; Maryam Hitier; Vahan Kepenekian; Koceila Lamine Amroun; Morgane Bouquot; Zaher Lakkis; Mehdi Ouaissi; Remi Darrius; Olivier Dubreuil; Emilie Duchalais; Nathan Moreno-Lopez; Bertrand Trilling; Johanna Zemour; Laura Beyer; Arnaud Alves; François Mauvais; Severine Noullet; Rodolfo Romero
Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: a retrospective study by AGEO

靶向疗法治疗转移性小肠腺癌的疗效：AGEO进行的一项回顾性研究

European Journal of Cancer
IF7.1
2026-03-280
PRE
Emeric Boisteau; Alice Boilève; David Tougeron; Dewi Vernerey; Alice De Malet; Thierry Lecomte; Thomas Aparicio; Simon Pernot; Julien Pinot; Anna Pellat; Vincent Hautefeuille; Nadim Farès; Romain Desgrippes; Romain Coriat; Aziz Zaanan; Julien Edeline; Sara Philonenko; Olivier Dubreuil; Julie Henriques; Anthony Turpin
Gastric cancer: French Intergroup clinical practice guidelines for diagnosis, staging, treatment and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACHBPT, RENAPE, SNFCP)

胃癌：法国多中心临床实践指南用于诊断、分期、治疗和随访（TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACHBPT, RENAPE, SNFCP）

European Journal of Cancer
IF7.1
2026-03-240
OAAI
Aziz Zaanan; Juliette Palle; Florence Renaud; Maximilien Barret; Meher Ben abdelghani; Bruno Buecher; Nicolas Chapelle; Olivier Dubreuil; Jerome Durand-Labrunie; Nadim Fares; Johan Gagniere; Marine Jary; Antoine Mariani; Lola-Jade Palmieri; Michel Ducreux; Olivier Bouché
Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES)

新辅助帕博利珠单抗联合观察等待策略治疗局部MSI/dMMR结直肠癌：一项随机GERCOR 109 – PRODIGE 84期II临床试验（PREMICES）的研究方案

Digestive and Liver Disease
IF3.8
2025-11-220
OAAI
Jérémie H. Lefevre; Olivier Dubreuil; Raphael Colle; David Tougeron; Angélique Vienot; Aurélien Dupré; Clémence Toullec; Denis Smith; Rosine Guimbaud; Benoist Chibaudel; Marie-Line Garcia Larnicol; Dewi Vernerey; Romain Cohen
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial

Zanzalintinib联合atezolizumab与regorafenib对比治疗难治性结直肠癌(STELLAR-303)：一项随机、开放标签、III期临床试验

The Lancet
IF97.3
2025-10-200
PRE
J Randolph Hecht; Young Suk Park; Josep Tabernero; Myung-Ah Lee; Soohyeon Lee; Anna C Virgili; Marc Van den Eynde; Elisa Fontana; Marwan Fakih; Gholamreza Asghari; Jane So; Alexander Stein; Olivier Dubreuil; Lubomir Bodnar; Cixin Steven He; Guan Wang; Robina Smith; Cathy Eng; Anwaar Saeed
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (PRODIGE 62-FFCD 1701-OESIRI)

Nal-IRI/LV5-FU 与紫杉醇作为转移性食管鳞状细胞癌患者二线治疗的比较（PRODIGE 62-FFCD 1701-OESIRI）

European Journal of Cancer
IF7.1
2025-08-220
OAAI
David Tougeron; Laurent Mineur; Aziz Zaanan; Melissa Kadi; Catherine Poisson Ligeza; Vincent Bourgeois; Jérôme Martin-Babau; Aurélie Fadin; Véronique Jestin le Tallec; Valérie Ly Lebrun; Olivier Dubreuil; Faiza Khemissa Akouz; Elsa Thimonier; Olivier Bouché; Astrid Lièvre; Frédéric Di Fiore; Thierry Lecomte; Côme Lepage; Vincent Hautefeuille
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study

瑞戈非尼联合伊立替康作为转移性胃食管腺癌的二线治疗：PRODIGE 58-UCGI35-REGIRI Unicancer随机II期研究的结果

ESMO OPEN
IF8.3
2025-05-010
OA
Samalin, E.; Evesque, L.; Turpin, A.; de la Fouchardiere, C.; Khemissa-Akouz, F.; Bouche, O.; Muller, M.; Dermeche, S.; Botsen, D.; Tougeron, D.; Zaanan, A.; Ben Abdelghani, M.; Guardiola, E.; Dubreuil, O.; Ly, V. Le Brun; Hennequin, A.; Watson, S.; Sefrioui, D.; Lecomte, T.; Carvalho, N. De Sousa; Hulin, A.; Crapez, E.; Castan, F.; Senellart, H.
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
ESMO OPEN
IF8.3
2024-09-014
OAAI
Gallois, C.; Bergen, E. S.; Auclin, E.; Pernot, S.; Higue, J.; Trouilloud, I.; Touchefeu, Y.; Turpin, A.; Mazard, T.; Sartore-Bianchi, A.; Prenen, H.; Alberti, A.; Pilla, L.; Cuissy, S.; Wookey, V.; Perret, A.; Melchior, C.; Artru, P.; Dubreuil, O.; Drouillard, A.; Doat, S.; Lavole, J.; Basile, D.; Perkins, G.; Jary, M.; Stintzing, S.; Jos, J.; Tougeron, D.; Taieb, J.
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study

Nal-IRI/LV5-FU 与 paclitaxel 作为转移性食管鳞状细胞癌患者二线治疗的比较（OESIRI-PRODIGE 62）：一项 FFCD 多中心、随机、II 期研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Tougeron, D.; Mineur, L.; Zaanan, A.; Kadi, M.; Ligeza, C. Poisson; Bourgeois, V.; Martin-Babau, J.; Fadin, A.; Jestin, V.; Le Brun-Ly, V.; Dubreuil, O.; Khemissa, F.; Thimonier, E.; Bouche, O.; Lievre, A.; Di Fiore, F.; Lecomte, T.; Desrame, J.; Lepage, C.; Hautefeuille, V.
IMHOTEP Phase II trial of neoadjuvant pembrolizumab in dMMR/MSI tumors: Results of the colorectal cancer cohort

IMHOTEP II期临床试验：新辅助培美曲塞治疗dMMR/MSI肿瘤的结果——结直肠癌队列

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
de la Fouchardiere, C.; Zaanan, A.; Cohen, R.; Le Sourd, S. M.; Tougeron, D.; Soularue, E.; Dubreuil, O.; Williet, N.; Samalin-Scalzi, E.; Piessen, G.; Hautefeuille, V.; Jary, M.; Ben Abdelghani, M.; Evesque, L.; Rochigneux, P.; Blanc, E.; Bibeau, F.; DeMontfort, A.; Coutzac, C.
IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI localized cancers: Results of the digestive non-colorectal cancer cohorts

IMHOTEP II期临床试验：新辅助培美曲塞在dMMR/MSI局部消化道非结直肠癌队列中的结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
de la Fouchardiere, C.; Zaanan, A.; Cohen, R.; Le Sourd, S. M.; Tougeron, D.; Soularue, E.; Dubreuil, O.; Williet, N.; Samalin-Scalzi, E.; Piessen, G.; Hautefeuille, V.; Jary, M.; Ben Abdelghani, M.; Evesque, L.; Rochigneux, P.; Blanc, E.; Bibeau, F.; DeMontfort, A.; Coutzac, C.
Trifluridine/tipiracil plus oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial
DIGESTIVE AND LIVER DISEASE
IF3.8
2024-08-010
OAAI
Botsen, Damien; Chabaud, Sylvie; Perrier, Herve; Ammarguellat, Hanifa; Jestin-Le-Tallec, Veronique; Olesinski, Jonathan; Toullec, Clemence; Aparicio, Thomas; Ben Abdelghani, Meher; Borg, Christophe; Bouche, Olivier; Coutzac, Clelia; Devaud, Herve; Di Fiore, Frederic; Dubreuil, Olivier; Evesque, Ludovic; Huguenin, Bruno; Muller, Marie; Poureau, Pierre-Guillaume; Oularue, Emilie; Tougeron, David; Zaanan, Aziz; Ammari, Samy; Carvalho, Nicolas De Sousa; Decazes, Pierre; De La Fouchardiere, Christelle
Randomised phase II study evaluating trifluridine/tipiracil (FTD/TPI) plus oxaliplatin ± nivolumab versus FOLFOX ± nivolumab in patients with HER2-negative locally advanced, recurrent or metastatic gastric, oesophageal or junctional adenocarcinoma (aGA/GEJA) (PRODIGE 73-LOGICAN)
ANNALS OF ONCOLOGY
IF65.4
2024-06-010
PRE
de la Fouchardiere, C.; Chabaud, S.; Perrier, H.; Ammarguellat, H.; Jestin, V.; Olesinski, J.; Toullec, C.; Aparicio, T.; Ben Abdelghani, M.; Bouche, O.; Coutzac, C.; Dubreuil, O.; Evesque, L.; Muller, M.; Poureau, P-G.; Soularue, E.; Tougeron, D.; Zaanan, A.; Carvalho, N. De Sousa; Botsen, D.

研究方向

暂未获取到该数据
D
David Tougeron
H 指数:51论文数:502被引数:1.0万
J
Julien Taı̈eb
H 指数:98论文数:1,374被引数:4.3万
A
Aziz Zaanan
H 指数:41论文数:268被引数:1.0万
O
Olivier Bouché
H 指数:83论文数:761被引数:4.2万
A
Anthony Turpin
H 指数:26论文数:263被引数:2,807
T
Thierry Lecomte
H 指数:53论文数:637被引数:1.4万
S
Simon Pernot
H 指数:30论文数:210被引数:5,863
T
Thomas Aparicio
H 指数:55论文数:482被引数:1.3万
C
Christelle de la Fouchardière
H 指数:57论文数:379被引数:2.7万
M
Méher Ben Abdelghani
H 指数:23论文数:128被引数:6,307